TABLE 1.
Chemotherapies | Propolis extracts | Source | Study type | Subjects | Key results | Molecular mechanisms | References |
---|---|---|---|---|---|---|---|
DOX | Ethanolic extract | Algeria | In vitro | Breast cancer cells (MDA-MB-231) | Potentiated antitumor effects | Inducing cell cycle arrest in the S phase | Rouibah et al. (2021) |
Normal cells (MRC-5) | Reduced multidrug resistance | Enhanced caspase-dependent apoptosis | |||||
Reduced cytotoxic effect in normal cells | A significant increase in intracellular DOX content by inhibiting p-gp | ||||||
Ethanolic and methanolic extract | Algeria | In vivo | DOX-induced mitochondrial stress in rats | Propolis protected heart and liver tissues from oxidative stress | Mitochondria protection by reducing malondialdehyde, restoring glutathione contents and catalase and superoxide dismutase activities | Badr et al. (2015) | |
Ethanolic extract | Australia | In vitro | MCF7 breast adenocarcinoma | Strong synergistic interaction (CI = 0.11) in inhibiting cell proliferation | Upregulated expression of pro-apoptotic protein cyclin-dependent kinase inhibitor 1B (p27), antioxidant PON2, Claspin and catalase, and downregulated expression of anti-apoptotic protein including XIAP, HSP60, and HIF-1α | Alsherbiny et al. (2021) | |
Propolis capsules | Australia | In vivo | DOX-induced multi-organ toxicity in rats | Pre-treatment with propolis significantly ameliorated DOX-induced cardiomyopathy, hepatotoxicity, nephritis, and pneumonia | Reduced apoptosis, oxidative stress and pro-inflammatory cytokines | Mohamed et al. (2021) | |
Hydroalcoholic extract | Brazil | In vivo | Wistar rats | The co-administration reduced chromosome damage induced by DOX compared to the group treated only with DOX | Free radical scavenging activity by the phenolic compounds in propolis | Tavares et al. (2007) | |
Methanolic extracts | Cuba | In vitro | Human colon carcinoma cells (LoVo Dox) | Synergistic antiproliferative and cytotoxic effect | Induced cell cycle arrest | Frión-Herrera et al. (2019) | |
Increased level of apoptosis | |||||||
Marked ROS production and drastic alteration of ΔΨm | |||||||
Ethanolic extract | Chandigarh, India | In vivo | DOX-induced hepatotoxicity in male rats | Administration of animals with propolis prior to DOX led to significantly reduced hepatotoxicity parameters in blood when compared to the doxorubicin-treated group. | Modulation of the oxidative damage related parameters in liver | Singla et al. (2014) | |
Propolis extract | Egypt | In vivo | DOX-induced cardiotoxicity and nephrotoxicity in rats | Propolis exhibited protective effects against DOX-induced cardiotoxicity and nephrotoxicity | Propolis attenuated cardiac oxidation and lowered lipid level | Ali et al. (2020) | |
Ethanolic extract | Egypt | In vivo | DOX-induced testicular toxicity in rats | Propolis extract ameliorated DOX-induced toxicity in testis without reducing its anti-cancer potential | Restored levels of testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) in normal and DOX-treated rats; restored testicular activities by regulating 3b-hydroxysteroid dehydrogenase (3b-HSD) and 17b-hydroxysteroid dehydrogenase (17b-HSD); free radicals scavenging and improving antioxidant enzymes in various tissues; reduced inflammatory and apoptotic responses | Rizk et al. (2014) | |
Aqueous extract | Egypt | In vivo | N-methyl-N-nitrosourea (MNU) induced adenocarcinoma in rats | The combination protected liver and kidney against the toxicity of DOX | Restored liver enzyme levels including albumin, globulin, ALT, AST, ALP; improved kidney function; improved activities of antioxidant enzymes | Badr et al. (2015) | |
Water extract of propolis | NA | In vivo | DOX-induced somatic mutation and recombination in Drosophila melanogaster | The combined treatment led to a reduction in the frequency of recombination compared to the treatment with DOX alone | NA | Valadares et al. (2008) | |
Ethanolic extract | NA | In vivo | DOX-induced hepatotoxicity in rats | Improved hepatoprotective effect shown as number of vacuolated hepatocytes with mild congestion in central veins | NA | Omar et al. (2016) | |
TEM | Ethanolic extract | NA | In vitro | U87MG glioblastoma | The combination therapy significantly reduced cell viability and proliferation | Reduced DNA synthesis, enhanced cell permeability, and significantly reduced NF-κB translocation | Markiewicz-Żukowska et al. (2013) |
Irinotecan | Ethanolic/aqueous extracts of propolis | NA | In vivo | Swiss albino mice injected with EAT | The combination with the ethanolic extract of propolis increased the life span of the tumor-bearing mice and decreased proliferation of the EAT compared to using irinotecan alone | NA | Benkovic et al. (2007); Lisičić et al. (2014) |
Ethanolic/aqueous extracts of propolis | NA | In vivo | Swiss albino mice injected with EAT | Combined treatment with aqueous or ethanolic extracts of propolis showed enhanced antitumor activity and prolonged survival in EAT-bearing mice | NA | Lisičić et al. (2014) | |
Water-soluble derivative of propolis | NA | In vivo | Swiss albino mice injected with EAT | The combination treatment resulted in substantial inhibitions of the growth of EAT cells; decreased genotoxic and cytotoxic to normal cells induced by irinotecan | Immunomodulatory effect regulating lymphocyte/polymorphonuclear leukocyte ratio | Oršolić et al. (2010) | |
5-Fu | Aqueous extract | Brazil | In vivo | EAT mouse model | The co-administration significantly increased tumor regression compared with using 5-Fu alone and significantly ameliorated the cytopenia induced by 5-FU | Restored white and red blood cell counts | Suzuki et al. (2002) |
Alcoholic extract | Iran | In vivo | AOM/DSS induced colorectal cancer in BALB-c mice | Propolis increased the anti-cancer of 5-Fu by further inhibiting the onset and progression of colorectal cancer | A greater decrease in Cox-2 and iNOS expression leading to reduced cell survival | Sameni et al. (2021) | |
MMC | Ethanolic extract | Turkey | In vitro | Human peripheral lymphocyte viability | The co-incubation of either propolis extract and MMC enhanced the cell viability of lymphocyte compared to using MMC alone | NA | Arslan et al. (2021) |
Ethanolic extract | Iraq | In vivo | Albino male mice | Propolis may have the potential to inhibit the genotoxic effects of MMC without compromising the anti-cancer activity of MMC | Immunomodulatory capacity of propolis through a significantly increased total count of leucocytes and mitotic index | Al-Halbosiy (2008) | |
Hydroethanolic extract | India | In vivo | Healthy adult male mice | The co-administration protected testis against the toxicity from MMC | Reduced DNA damage, elevated the anti-oxidant activity, restored the testicular testosterone and inhibin B level | Kumari et al. (2017) | |
Hydroethanolic extract | NA | In vivo | MMC-induced bone marrow toxicity in Swiss albino mice | Hydroethanolic extract of propolis possessed substantial geno- and cytoprotective properties against MMC | Free radical scavenging activity of propolis | Kumari et al. (2016) | |
Aqueous extract | NA | In vivo | EAT mouse model | Significantly increased tumor regression compared to using MMC alone and attenuated cytopenia induced by MMC | Restored white blood cells, red blood cells, and platelet counts | Suzuki et al. (2002) | |
PDT | Ethanolic extract | Seoul, South Korea | In vitro | Human head and neck cancer cells AMC-NH-4 | The combined treatment enhanced the inhibition of tumor cell viability and increased apoptotic level | Upregulated caspase-mediated cell apoptosis | Ahn et al. (2013) |
Ethanolic extract of green propolis | Brazil | In vitro and in vivo | Human epidermoid carcinoma A431 cell and cervical cancer HeLa cell, xenograft mouse model | Synergistic effect (CI < 1) in reducing tumor cell viability in the combination and suppressed inflammatory response | Increased PDT intracellular uptake and accumulation; upregulated Bax/Bcl-xL and caspase-mediated cell apoptotic level; inhibited pIKK-NFκB signaling pathway | Wang et al. (2017) |
NA, not available.